Skip to Main Content

Residents & Fellows

Yale School of Medicine/

Yale Cancer Center

Yale Cancer Center

Patient Information
- Cancer Types
  Chênevert Family Brain Tumor Center
  Center for Breast Cancer
  Endocrine Cancers Program
  Center for Gastrointestinal Cancers
  Gynecologic Oncology Program
  Head & Neck Cancers Program
  Hematology Program
  Liver Cancer Program
  Skin & Kidney Cancer Program
  Pediatric Hematology & Oncology Program
  Prostate & Urologic Cancers Program
  Sarcoma Program
  Center for Thoracic Cancers
- Specialty Programs
  Cancer Genetics and Prevention
  Screening & Prevention
  Early Onset Cancer Program
  Early Onset Cancers
  Programs
  Resources
  Research
  PROSPER
  Cardio-Oncology
  Integrative Medicine
  Interventional Oncology
  Ocular Oncology
  Onco-Dermatology
  Pain Program
  Palliative Care
  Psycho-Oncology
  Sexuality, Intimacy & Menopause Program
  Survivorship Clinic
  Tobacco Treatment
News

Research & Education
Make a Gift

About Us
Contact Us

Diversity
Intranet

INFORMATION FOR

About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni

Treatment of Tumors Resistant to PD-1 Inhibitors

June 03, 2019

October 4, 2018 | Harriet Kluger MD

Information

ID: 1564
To Cite: DCA Citation Guide

Yale Cancer Center
PO Box 208028
New Haven, CT 06520-8028
Maps & Directions
174 Events
you could attend in November 2024
Calendar
Contact Us

Intranet
Site Editor
Accessibility at YSM
Nondiscrimination & Title IX
Safety & Security
Terms & Privacy Statement
Yale University

© 2024 Yale School of Medicine. Updated 09/17/2024

Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads